Is MCS Psychological or Physical? What the Evidence Says

A plain-language comparison of the 2024–2025 Brain Sciences debate — the two competing clinical views, where they agree, where they clash, and which side the current evidence favors.

Start with what is not in dispute: your symptoms are real, and both sides of this debate agree on that. The disagreement is about cause — and on the evidence, the side arguing MCS is a physical, body-based condition has the far stronger hand: measurable nerve changes, immune findings, genetics, and symptoms that drop when the air is cleaned. Stress can turn the volume up, as it does in many physical illnesses — but that does not make this “all in your head,” and no current science supports that claim.

Multiple Chemical Sensitivity (MCS) is one of the most contested conditions in medicine. In 2024, a paper in the journal Brain Sciences argued it is mainly a psychological condition. In 2025, the same journal published a formal rebuttal arguing it is a real, physical, multi-system illness. This page lays out both positions in plain terms, side by side, so you can see exactly where they agree, where they clash, and which side the current evidence favors.

What is MCS, and what exactly is being debated?

People with MCS report real, sometimes disabling symptoms — trouble breathing, racing heart, brain fog, nausea — from everyday low-level exposures most people tolerate. Standard tests usually come back normal, which is much of why the cause stays disputed.

What do the two key papers say?

View 1 — Psychological

Paper: Jacques (2024), Brain Sci. 14:1261

Core claim: MCS is primarily psychogenic — driven by unresolved emotional trauma and chronic stress responses.

Main evidence: Literature review plus clinical experience; comparison with psychiatric comorbidities; three patient case studies.

Treatment implication: Target the mind and stress response (psychological and stress-directed therapies).

View 2 — Biological / Multi-system

Paper: Psaradellis (2025), Brain Sci. 15:747 — a Comment replying to Jacques

Core claim: MCS is a genuine physical condition with measurable biology; it cannot be reduced to psychology.

Main evidence: Receptor and oxidative-stress studies, a VOC-reduction trial, genetic and immune (mast-cell) data, legal rulings, and ICD-10 recognition abroad.

Treatment implication: Reduce chemical exposure and treat the underlying biology; address psychology as a consequence, not the cause.

What is the psychological model of MCS?

Source: Jacques, L. “Multiple Chemical Sensitivity: A Clinical Perspective.” Brain Sciences, 2024, 14(12), 1261. The author writes from an occupational and environmental medicine clinic at a Montreal university hospital.

The Position

MCS develops mainly out of unresolved emotional trauma and the body’s chronic and acute stress reactions. In this view, the symptoms are real but the engine driving them is psychological, not the chemicals themselves.

How it is argued. The paper reviews the published literature alongside the author’s own clinical experience, then compares brain-imaging and biomarker findings in MCS patients against findings in the conditions that frequently travel with MCS — many of which are psychiatric, such as anxiety and depression. It illustrates the model with three patient case studies.

What it implies. If trauma and stress are the root, the most effective help is psychological and stress-directed — retraining the stress response rather than chasing the chemicals.

What is the biological model of MCS?

Source: Psaradellis, E. “Redefining Clinical Perspectives on MCS: Toward an Evidence-Based, Multisystem Model.” Brain Sciences, 2025, 15(7), 747. This is a formal Comment written specifically to rebut the 2024 paper, funded by the Environmental Health Association of Québec.

The Position

MCS is a real, physical, multi-system condition with measurable biological signatures. Psychology matters — but mostly as the emotional toll of living with a stigmatized illness, not as its cause.

The rebuttal builds its case on five separate lines of evidence:

  • Measurable body changes. MCS patients show objective physical markers — elevated oxidative stress, altered brain activation, and “receptor sensitization”: the nerve channels that sense irritants (called TRPV1 and TRPA1) become over-reactive. The paper notes that 21 separate receptor-challenge studies (19 capsaicin, 2 acrolein) point to this receptor sensitization as a key mechanism.
  • Remove the chemical, symptoms drop. A clinical study found that improving indoor air quality by cutting volatile organic compounds (VOCs) produced significant symptom improvement. A purely psychological condition would not be expected to respond so directly to cleaning up the air.
  • Genetics. Certain inherited gene variants raise the odds of MCS. Carriers of specific chemical-processing genes (CYP2D6 and NAT2) showed three- to four-fold higher odds of having the condition in the original study — real, biologically plausible evidence, though later attempts to replicate it have been inconsistent (one follow-up found the NAT2 association held only in the most severely affected patients). Newer 2025 genetic findings elsewhere in the field continue to build the broader case independently.
  • Immune involvement. In a survey of over 10,000 U.S. adults, people with the highest markers of mast cell activation (an immune-system response) had more than six times the odds of chemical intolerance — tying MCS to a concrete immune mechanism.
  • Official and legal recognition. Germany, Japan, and Spain formally recognize MCS as an environmental health condition with official ICD-10 diagnostic codes, and several Canadian workplace-accommodation rulings have accepted its physical basis.

A direct hit on the 2024 evidence. The rebuttal’s sharpest point is about Jacques’s case studies: it argues two of the three actually describe carbon monoxide poisoning — a completely different condition from MCS — and that the paper never explains how those cases were selected, which weakens them as support for a psychological model.

What do both sides actually agree on?

Both sides actually agree on one mechanism: sensitization. Something tips the body into an over-reactive state, so tiny exposures set off an outsized alarm. The argument is about what trips it, not whether it's real.

Where they split. View 1 says the dominant trigger is psychological — trauma and a stuck stress response. View 2 says the dominant trigger is physical — chemical exposure acting on sensitized nerves, genes, and the immune system. One starts in the mind and reaches the body; the other starts in the body and affects the mind.

Which side the evidence favors. On raw empirical weight, View 2 has the stronger hand: it brings genetic data, receptor studies, immune findings, and a study showing symptoms fall when the air is cleaned. View 1 is pointing at something real that the biological camp tends to underweight — the well-documented way stress and emotional state can amplify symptoms — but it leans on case studies the rebuttal shows are shaky.

The Mature Reading

These are not two incompatible diseases. They are two inputs into the same sensitized system. For most patients both matter — a physical trigger sets the condition up, and stress or emotional state turns the volume up or down. Any source claiming a single, settled cause — purely psychological or purely chemical — is overstating what the science currently supports.

What biases shape each side?

Neither of these facts decides the science, but both are worth knowing when you weigh how confident each paper sounds:

  • View 1 comes from occupational medicine — a field that has historically been more skeptical of MCS as a physical disease, which may tilt it toward a psychological reading.
  • View 2 was funded by a patient-advocacy organization with a direct stake in MCS being classified as a physical condition, which may tilt it toward a biological reading.

The honest takeaway is to weigh the underlying studies on their own merits rather than trusting either paper’s tone of certainty.

If You Only Remember Four Things

  • MCS symptoms are real and can be disabling — that is not in dispute.
  • The current evidence leans toward a physical, multi-system cause (nerves, genes, immune system), not a purely psychological one.
  • Stress and emotional state clearly influence symptoms, which is why mind-and-stress approaches sometimes help — but that does not make the condition “all in your head.”
  • Reducing chemical exposure has measurable benefit, so cleaning up a person’s environment is a legitimate, evidence-backed step.

Frequently Asked

Is MCS real?

Yes. The symptoms are real and can be disabling — that is not in dispute between either side of the clinical debate. What was debated is the cause, and the current evidence leans toward a physical, multi-system mechanism.

Is MCS psychological?

A purely psychological cause is not supported by current science. People with MCS show measurable changes in their nerves, genes, and immune system, and symptoms fall when chemical exposure is reduced. Stress and emotional state can amplify symptoms, but that is an input that turns the volume up or down — not the root cause.

Does reducing chemical exposure help?

Yes. A clinical study found that improving indoor air quality by cutting volatile organic compounds (VOCs) produced significant symptom improvement. A purely psychological condition would not be expected to respond so directly to cleaning up the air, which is one of the strongest pieces of evidence for a physical mechanism.

Key Studies Referenced

The two papers in the debate:

1 Jacques, L. (2024). Multiple Chemical Sensitivity: A Clinical Perspective. Brain Sciences, 14(12), 1261. doi:10.3390/brainsci14121261
2 Psaradellis, E. (2025). Redefining Clinical Perspectives on MCS: Toward an Evidence-Based, Multisystem Model. Comment on Jacques (2024). Brain Sciences, 15(7), 747. doi:10.3390/brainsci15070747

The primary studies the rebuttal relies on:

3 Molot, J., Sears, M., & Anisman, H. (2023). Multiple Chemical Sensitivity: It’s time to catch up to the science. Neuroscience & Biobehavioral Reviews, 151, 105227. (Synthesis of receptor-sensitization and oxidative-stress evidence.)
4 Perales, R. B., Palmer, R. F., Rincon, R., et al. (2022). Does improving indoor air quality lessen symptoms associated with chemical intolerance? Environmental Health Perspectives, 130, 017002. (VOC-reduction symptom study.)
5 McKeown-Eyssen, G., Baines, C., Cole, D. E., et al. (2004). Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. International Journal of Epidemiology, 33, 971–978. (Genetic susceptibility.)
6 Miller, C. S., Palmer, R. F., Kattari, D., et al. (2023). What initiates chemical intolerance? Findings from a large population-based survey of U.S. adults. Environmental Sciences Europe, 35, 65. (Mast-cell / immune link.)
7 Palmer, R. F., Almeida, M., Perales, R. B., & Rincon, R. (2023). A genome-wide SNP investigation of chemical intolerance. Environmental Advances, 12, 100380. (Gene–environment interaction.)
8 McKeown-Eyssen, G. E., Baines, C. J., Marshall, L. M., et al. (2001). Multiple chemical sensitivity: Discriminant validity of case definitions. Archives of Environmental Health, 56, 406–412. (The 1999 consensus definition used to flag the misclassified case studies.)

Medical Disclaimer

This summary is for general information and discussion. It is not medical advice and does not diagnose or treat any condition. Claims are drawn from the published papers cited above; readers are encouraged to consult the original sources and work with healthcare providers familiar with environmental illness.

← Back to MCSDisability.com